A Young Man with Numbness in Arms and Legs: From the National Multiple Sclerosis Society Case Conference Proceedings

Overview

Journal Neurol Neuroimmunol Neuroinflamm

Specialty Neurology

Date 2018 Nov 23

PMID 30465017

Citations 1

Authors

Andrew R Romeo

Robert P Lisak

Ethan Meltzer

Edward J Fox

Esther Melamed

Ashlea Lucas

Leorah Freeman

Teresa C Frohman

Kathleen Costello

Scott S Zamvil

Elliot M Frohman

Jeffrey M Gelfand

Affiliations

Soon will be listed here.

Citing Articles

Diagnostic and treatment challenges, a new section in N2.

Dalmau J Neurol Neuroimmunol Neuroinflamm. 2018; 5(6):e511.

PMID: 30465018 PMC: 6225925. DOI: 10.1212/NXI.0000000000000511.

References

Cotton F, Weiner H, Jolesz F, Guttmann C . MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology. 2003; 60(4):640-6. DOI: 10.1212/01.wnl.0000046587.83503.1e. View

Stern B, Royal 3rd W, Gelfand J, Clifford D, Tavee J, Pawate S . Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018; 75(12):1546-1553. DOI: 10.1001/jamaneurol.2018.2295. View

Wingerchuk D, Banwell B, Bennett J, Cabre P, Carroll W, Chitnis T . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015; 85(2):177-89. PMC: 4515040. DOI: 10.1212/WNL.0000000000001729. View

Tahmoush A, Amir M, Connor W, Farry J, Didato S, Ulhoa-Cintra A . CSF-ACE activity in probable CNS neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2002; 19(3):191-7. View

. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002; 59(4):499-505. DOI: 10.1212/wnl.59.4.499. View

Krumholz A, Stern B . Neurologic manifestations of sarcoidosis. Handb Clin Neurol. 2013; 119:305-33. DOI: 10.1016/B978-0-7020-4086-3.00021-7. View

DeRemee R, Rohrbach M . Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Intern Med. 1980; 92(3):361-5. DOI: 10.7326/0003-4819-92-3-361. View

Marangoni S, Argentiero V, Tavolato B . Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol. 2005; 253(4):488-95. DOI: 10.1007/s00415-005-0043-5. View

Gelfand J . Demystifying Neurosarcoidosis and Informing Prognosis. JAMA Neurol. 2017; 74(11):1296-1298. DOI: 10.1001/jamaneurol.2017.1473. View

10.

Flanagan E, Kaufmann T, Krecke K, Aksamit A, Pittock S, Keegan B . Discriminating long myelitis of neuromyelitis optica from sarcoidosis. Ann Neurol. 2015; 79(3):437-47. DOI: 10.1002/ana.24582. View

11.

Nguyen C, Kambe N, Kishimoto I, Ueda-Hayakawa I, Okamoto H . Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement. J Dermatol. 2017; 44(7):789-797. DOI: 10.1111/1346-8138.13792. View

12.

Zajicek J, Scolding N, Foster O, Rovaris M, Evanson J, Moseley I . Central nervous system sarcoidosis--diagnosis and management. QJM. 1999; 92(2):103-17. DOI: 10.1093/qjmed/92.2.103. View

13.

Broos C, Koth L, van Nimwegen M, In t Veen J, Paulissen S, van Hamburg J . Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes. Eur Respir J. 2018; 51(3). DOI: 10.1183/13993003.01124-2017. View

14.

Gelfand J, Bradshaw M, Stern B, Clifford D, Wang Y, Cho T . Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. Neurology. 2017; 89(20):2092-2100. PMC: 5711506. DOI: 10.1212/WNL.0000000000004644. View

15.

Frohman E, Wingerchuk D . Clinical practice. Transverse myelitis. N Engl J Med. 2010; 363(6):564-72. DOI: 10.1056/NEJMcp1001112. View

16.

Khoury J, Wellik K, Demaerschalk B, Wingerchuk D . Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist. 2009; 15(2):108-11. DOI: 10.1097/NRL.0b013e31819bcf84. View

17.

Ramstein J, Broos C, Simpson L, Ansel K, Sun S, Ho M . IFN-γ-Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells. Am J Respir Crit Care Med. 2015; 193(11):1281-91. PMC: 4910899. DOI: 10.1164/rccm.201507-1499OC. View

18.

Zalewski N, Krecke K, Weinshenker B, Aksamit A, Conway B, McKeon A . Central canal enhancement and the trident sign in spinal cord sarcoidosis. Neurology. 2016; 87(7):743-4. DOI: 10.1212/WNL.0000000000002992. View

19.

Cree B . Acute inflammatory myelopathies. Handb Clin Neurol. 2014; 122:613-67. DOI: 10.1016/B978-0-444-52001-2.00027-3. View

20.

Gronhagen-Riska C, Selroos O, Wagar G, Fyhrquist F . Angiotensin-converting enzyme. II. Serum activity in early and newly diagnosed sarcoidosis. Scand J Respir Dis. 1979; 60(2):94-101. View